{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T18:00:31Z","timestamp":1765994431655},"reference-count":26,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Immunology"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1016\/j.humimm.2017.06.004","type":"journal-article","created":{"date-parts":[[2017,6,11]],"date-time":"2017-06-11T11:31:30Z","timestamp":1497180690000},"page":"629-633","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Circulating angiotensin type II receptor: Possible marker for antibody mediated rejection after renal transplantation?"],"prefix":"10.1016","volume":"78","author":[{"given":"Pamela M.","family":"Kimball","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gaurav","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Felecia","family":"McDougan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.humimm.2017.06.004_b0005","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1177\/1526924816640678","article-title":"Perioperative desensitization improves outcomes among crossmatch positive recipients of deceased donor renal transplants","volume":"26","author":"Sharma","year":"2016","journal-title":"Prog. Transplant."},{"key":"10.1016\/j.humimm.2017.06.004_b0010","doi-asserted-by":"crossref","unstructured":"I. Salvade, V. Aubert, J. Venetz, et al., Clinically relevant threshold of preformed donor-specific anti-HLA antibodies in kidney transplantation, Hum. Immunol. 77 (2016) 483\u2013489.","DOI":"10.1016\/j.humimm.2016.04.010"},{"key":"10.1016\/j.humimm.2017.06.004_b0015","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1053\/j.ajkd.2015.03.033","article-title":"Humoral response and allograft function in kidney transplantation","volume":"15","author":"Filippone","year":"2015","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.humimm.2017.06.004_b0020","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1038\/ki.2010.556","article-title":"Surveillance of alloantibodies after transplantation identifies the risk of chronic rejection","volume":"79","author":"Kimball","year":"2011","journal-title":"Kidney Int."},{"key":"10.1016\/j.humimm.2017.06.004_b0025","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1097\/TP.0000000000000511","article-title":"Characteristics of circulating donor human leukocyte antigen-specific immunoglobulin G antibodies predictive of acute antibody-mediated rejection and kidney allograft failure","volume":"99","author":"Kannabhiran","year":"2015","journal-title":"Transplantation"},{"key":"10.1016\/j.humimm.2017.06.004_b0030","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1093\/ndt\/gfr429","article-title":"Clinical relevance of HLA donor specific antibodies detected by single antigen assay in kidney transplantation","volume":"27","author":"Caro-Oleas","year":"2012","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.humimm.2017.06.004_b0035","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/TP.0b013e31827a19cc","article-title":"Consensus guidelines on the testing and clinical management issues a associated with HLA and non-HLA antibodies in transplantation","volume":"95","author":"Tait","year":"2013","journal-title":"Transplantation"},{"key":"10.1016\/j.humimm.2017.06.004_b0040","article-title":"Anti-angiotensin II type 1 receptor and anti-endothelial cell antibodies: a cross sectional analysis of pathological findings in allograft biopsies","author":"Philogene","year":"2016","journal-title":"Transplantation"},{"key":"10.1016\/j.humimm.2017.06.004_b0045","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1111\/tri.12371","article-title":"The influence of non-HLA antibodies directed against angiotensin II type receptor (AT1R) on early renal transplant outcomes","volume":"27","author":"Banaski","year":"2014","journal-title":"Transplant. Int."},{"key":"10.1016\/j.humimm.2017.06.004_b0050","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1016\/j.humimm.2013.07.002","article-title":"Interplay between immune responses to HLA and non-HLA self-antigens in allograft rejection","volume":"74","author":"Angaswamy","year":"2013","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.humimm.2017.06.004_b0055","doi-asserted-by":"crossref","first-page":"314","DOI":"10.3343\/alm.2015.35.3.314","article-title":"Investigation of serum angiotensin II type receptor antibodies at the time of renal allograft rejection","volume":"35","author":"Lee","year":"2015","journal-title":"Ann. Lab. Med."},{"key":"10.1016\/j.humimm.2017.06.004_b0060","doi-asserted-by":"crossref","first-page":"2618","DOI":"10.1016\/j.transproceed.2014.09.029","article-title":"Non-HLA antibodies: angiotensin II type 1 receptor (anti-AT1R) and endothelin-1 type A receptor (anti-ETAR) are associated with renal allograft injury and graft loss","volume":"46","author":"Banasik","year":"2014","journal-title":"Transplant. Proc."},{"key":"10.1016\/j.humimm.2017.06.004_b0065","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1111\/nep.12441","article-title":"C4d-negative antibody mediated rejection with high anti-angiotensin II type 1 receptor antibodies in absence of donor specific antibodies","volume":"20","author":"Fuss","year":"2015","journal-title":"Nephrology"},{"key":"10.1016\/j.humimm.2017.06.004_b0070","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.coph.2015.01.004","article-title":"Angiotensin type 2 receptors: blood pressure regulation and end organ damage","volume":"21","author":"Sumners","year":"2015","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.humimm.2017.06.004_b0075","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1111\/1440-1681.12059","article-title":"Role of angiotensin AT2 receptors in natriuresis: intrarenal mechanisms and therapeutic potential","volume":"40","author":"Carey","year":"2013","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.humimm.2017.06.004_b0080","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1161\/HYPERTENSIONAHA.111.00241","article-title":"The intrarenal renin-angiotensin and dopaminergic systems. Control of renal sodium excretion and blood pressure","volume":"61","author":"Carey","year":"2013","journal-title":"Hypertension"},{"key":"10.1016\/j.humimm.2017.06.004_b0085","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1016\/j.cellsig.2014.06.011","article-title":"A century old renin-angiotensin system still grows with endless possibilities: AT1 receptor signaling cascades in cardiovascular physiopathology","volume":"26","author":"Balakumar","year":"2014","journal-title":"Cell. Signal."},{"key":"10.1016\/j.humimm.2017.06.004_b0090","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1038\/labinvest.2008.128","article-title":"Angiotensin II receptor blockade inhibits acute glomerular injuries with the alteration of receptor expression","volume":"89","author":"Mii","year":"2009","journal-title":"Lab. Invest."},{"key":"10.1016\/j.humimm.2017.06.004_b0095","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1056\/NEJMoa035717","article-title":"Angiotensin II type 1 receptor activating antibodies in renal allograft rejection","volume":"352","author":"Dragun","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.humimm.2017.06.004_b0100","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1097\/01.TP.0000436927.08026.a8","article-title":"Increased negative impact of donor HLA specific together with non-HLA specific antibodies on graft outcome","volume":"97","author":"Reinsmoen","year":"2014","journal-title":"Transplantation"},{"key":"10.1016\/j.humimm.2017.06.004_b0105","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/TP.0b013e3182529bb7","article-title":"Renal ischemia and transplantation predispose to vascular constriction mediated by angiotensin II type 1 receptor activating antibodies","volume":"94","author":"Lukitsch","year":"2012","journal-title":"Transplantation"},{"key":"10.1016\/j.humimm.2017.06.004_b0110","doi-asserted-by":"crossref","first-page":"2577","DOI":"10.1111\/ajt.12395","article-title":"Higher risk of kidney graft failure in the presence of anti-angiotensin II type 1 receptor antibodies","volume":"13","author":"Taniguchi","year":"2013","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.humimm.2017.06.004_b0120","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1097\/MOT.0b013e3283636e55","article-title":"Non-HLA antibodies in solid organ transplantation: recent concepts and clinical relevance","volume":"18","author":"Dragun","year":"2013","journal-title":"Curr. Opin. Organ Transplant."},{"key":"10.1016\/j.humimm.2017.06.004_b0125","doi-asserted-by":"crossref","DOI":"10.1111\/petr.12728","article-title":"Angiotensin II type 1 receptor antibodies in childhood kidney transplantation","author":"Bjerre","year":"2016","journal-title":"Pediatr. Transplant."},{"key":"10.1016\/j.humimm.2017.06.004_b0130","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1164\/rccm.201403-0442OC","volume":"190","author":"Becker","year":"2014","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.humimm.2017.06.004_b0135","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/ki.2015.320","article-title":"AT1 receptor antagonism before ischemia prevents the transition of acute kidney injury to chronic kidney disease","volume":"89","author":"Rodriquez-Romo","year":"2016","journal-title":"Kidney Int."}],"container-title":["Human Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0198885917300939?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0198885917300939?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,31]],"date-time":"2018-08-31T19:29:28Z","timestamp":1535743768000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0198885917300939"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":26,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2017,10]]}},"alternative-id":["S0198885917300939"],"URL":"https:\/\/doi.org\/10.1016\/j.humimm.2017.06.004","relation":{},"ISSN":["0198-8859"],"issn-type":[{"type":"print","value":"0198-8859"}],"subject":[],"published":{"date-parts":[[2017,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Circulating angiotensin type II receptor: Possible marker for antibody mediated rejection after renal transplantation?","name":"articletitle","label":"Article Title"},{"value":"Human Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humimm.2017.06.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Published by Elsevier Inc. on behalf of American Society for Histocompatibility and Immunogenetics.","name":"copyright","label":"Copyright"}]}}